Nasdaq · Biotech stocks database
BTMD (Biote Corp.) stock: $1.06, $38.1M market cap, $11.2M cash, $145.3M EV, $44.7M fully diluted market cap. Data from Fully Diluted's biotech stocks database.
Our future growth and profitability largely depends on our ability to increase practitioner awareness of the Biote Method as well as our Biote-branded dietary supplements, and on the willingness of clinics, practitioners and their patients to adopt them. Practitioners may not adopt the Biote Method unless they determine, based on experience, clinical data, medical society recommendations and other analyses, that the Biote Method and the Biote-branded dietary supplements are appropriate for their patients.
Source: 10-K FY2025 via SEC EDGAR
| Cash | $11.2M |
|---|---|
| Debt | $118.4M |
| Net cash | -$107.2M |
| Enterprise value | $145.3M |
| Basic shares | 28.7M shares |
| Fully diluted shares | 42.2M shares |
| Fully diluted market cap | $44.7M |
| Cash per share | $0.39 |
| Quarterly burn | $1.2M |
| Cash runway | 9.5 quarters |
Cash figures as of 2026-06-30. Database snapshot: 2026-11-07.
Cap table as of 2026-06-30.
Loading BTMD daily closes…